Table 1 Results of univariate analysis for prognosis evaluated by Kaplan‐Meier method.

Factors	Overall survival		Event‐free survival
	5 years	p Value*	5 years	p Value*
Age (y)
⩽58 or younger (n = 39)	0.94	0.072	0.91	0.069
⩾59 or older (n = 51)	0.84		0.79
Gender
Male (n = 47)	0.82	0.071	0.80	0.197
Female (n = 43)	0.95		0.90
Macroscopic type
Superficial (n = 71)	0.93	0.019	0.90	0.017
Others (n = 19)	0.71		0.65
Depth of tumour invasion
Mucosa (n = 37)	1.00	0.013	0.94	0.083
SM or beyond (n = 53)	0.81		0.79
Clinical stage
I (n = 61)	0.87	0.369	0.83	0.423
II1 or more (n = 29)	0.92		0.88
t(11;18)/API2‐MALT1
Positive (n = 18)	1.00	0.370	1.00	0.229
Negative (n = 69)	0.85		0.80
IGH‐involved translocation
Positive (n = 4)	1.00	0.507	0.75	0.583
Negative (n = 64)	0.87		0.84
Extra copies of MALT1
Positive (n = 18)	0.71	0.144	0.54	0.003
Negative (n = 53)	0.89		0.89
Extra copies of FOXP1
Positive (n = 10)	0.90	0.949	0.79	0.647
Negative (n = 49)	0.87		0.83

FOXP1, forkhead box protein P1; MALT, mucosa‐associated lymphoid tissue. *Log‐lank test.